Episode Details

A woman with three debilitating autoimmune diseases underwent CAR-T cell therapy at University Hospital Erlangen, Germany, resulting in a remarkable recovery. The treatment, which involves engineering T-cells to target rogue B-cells, led to a complete shutdown of her conditions within weeks. She has been in full remission for fourteen months without medication, with her B-cells regenerating healthily. Experts are optimistic about CAR-Ts potential in treating autoimmune diseases, with trials underway for lupus and multiple sclerosis.

Support the show:
Get a discount at https://solipillow.com/discount/dnn.

Advertise on DNN:
advertise@thednn.ai

This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.

View sources & latest updates:
https://sources.thednn.ai/f29bd8066edcfd14